Nano Nuclear Energy Inc. (NNE) stock intrinsic value fair value estimate & owner earnings analysis

NANO Nuclear Energy is a development-stage company designing small nuclear microreactors. Its lead project is the KRONOS MMR, a stationary high-temperature gas-cooled reactor using TRISO fuel, acquired in January 2025 from the bankrupt Ultra Safe Nuclear Corporation together with the LOKI MMR design. It also holds the ZEUS design and is selling its ODIN design (a letter of intent with Cambridge Atom Works, September 2025, with a $250,000 non-refundable down payment received). The company says it aims to launch KRONOS commercially in the early 2030s. It has no product revenue: fiscal 2025 income was about $5.6 million of interest, plus small consulting and lease receipts. What we credit and what we leave out. We value only what is already true. The company has no reactor licence, no customer contract for a reactor and no revenue-producing operations, so we credit no future earnings in any case. Its plans (a full-scale KRONOS demonstration with the University of Illinois Urbana-Champaign, NRC licensing, the Chalk River project in Ontario, manufacturing in Illinois) are real activities, but none has yet produced a signed sale, so they carry no value in our numbers. What they do carry is cost. Value therefore comes from cash on hand minus the cost of the development programme. The balance sheet. At June 30, 2026 the company held about $298 million of cash and $282 million of short-term investments, roughly $580 million in total, largely from an equity raise of about $379 million net in October 2025. It has no borrowings, so nothing is deducted for debt; its roughly $12 million of liabilities are ordinary payables and accruals that already run through the cost of operating. Diluted share count is about 53.7 million. How much the business burns. Owner earnings (cash from operations less working-capital swings, stock compensation and capital spending) were about -$6 million in fiscal 2023, -$11 million in 2024 and -$47 million in 2025, per diluted share -$0.28, -$0.43 and -$1.24. Stock compensation is treated as a real cost: it was $18.8 million in fiscal 2025. Because cash held earns interest that already sits inside operating cash flow, we strip out about $15.7 million of interest income earned in the first nine months of fiscal 2026 so it is not counted twice alongside the cash itself. On that basis the business consumed roughly $70 million a year in the most recent nine months, and the operating loss in the June 2026 quarter ($15.8 million) is well above the year-earlier quarter ($9.4 million). Management states losses will keep rising as it builds facilities and pursues licensing, and that significant additional capital will be needed. Not every earlier year is comparable: the business as it exists today begins with the January 2025 acquisition and the October 2025 raise. Bull case: about $5.42 per share. The company keeps spending at its demonstrated pace of about $70 million a year for five years, hits its milestones, and the programme then stops with nothing further credited. Business worth: minus $295 million; cash of $580 million; debt of zero; difference about $285 million, plus about $6 million from the $6.8 million of Illinois incentive awards tied to its planned Illinois facility, which is the one contractually stated inflow we can name. About $291 million, or $5.42 per share. Base case: about $3.59 per share. Spending rises with the announced buildout (the Oak Brook demonstration site, the more than $12 million Illinois manufacturing and R&D facility, fuel qualification and licensing work) from about $80 million to $100 million a year over five years, with nothing credited in return. Business worth: minus $394 million; cash $580 million; debt zero; difference about $187 million plus about $6 million of incentives, about $193 million, or $3.59 per share. Bear case: about $0.70 per share. Costs run to $90 million rising to $150 million a year as construction, fuel testing and regulatory work prove more expensive than planned and yield no customer commitments. Business worth: minus $549 million; cash $580 million; debt zero; difference about $32 million plus incentives, about $38 million, or $0.70 per share. We do not model a further share issue; any new equity would come in at market prices and would dilute holders without changing this per-share arithmetic materially. What we did not do. We did not assign value to the possibility that KRONOS or LOKI is licensed and sold, because no licence or contract exists. We did not credit the ODIN sale beyond the deposit already received because the price is not stated in the filing. We did not count the Oak Brook property (purchased for $3.5 million) or intellectual property as separate value. We value cash at face and ignore the modest interest it will earn while it is spent. What would make this wrong. Upside: an NRC or Canadian Nuclear Safety Commission licence, or a binding customer order, would create earning power we currently value at zero; those events would need to be named and evidenced before we would credit them. Downside: cost overruns beyond our bear case, or further share issuance at low prices. The company itself notes that the design and demonstration schedule depends on coordination with federal and state agencies. The filings do not disclose a reactor cost-to-complete figure, so our spending paths are judgements built from the recent run-rate and stated plans, not company forecasts.